Weiyan Peng
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Wnt/β-catenin signaling in development and cancer
- Inflammasome and immune disorders
Papers in
-
- Epigenetics and DNA Methylation 15
- Cancer-related gene regulation 12
- Wnt/β-catenin signaling in development and cancer 7
- RNA modifications and cancer 4
- Genomics and Chromatin Dynamics 3
-
- Erythrocyte Function and Pathophysiology 6
- Co-authors
- Tingxiu Xiang (33 shared papers)Guosheng Ren (23 shared papers)Zhu Qiu (8 shared papers)Lili Li (16 shared papers)Qian Tao (13 shared papers)Xuedong Yin (7 shared papers)Jun Tang (9 shared papers)Junhao Mu (9 shared papers)
- Journals
- Theranostics (3 papers)Journal of Cellular and Molecular Medicine (3 papers)Clinical Epigenetics (3 papers)Oncotarget (2 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weiyan Peng
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 246
- Molecular Biology 711
- Complementary and alternative medicine 64
- Oncology 171
- Immunology 105
Countries citing papers authored by Weiyan Peng
This map shows the geographic impact of Weiyan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Peng more than expected).
Fields of papers citing papers by Weiyan Peng
This network shows the impact of papers produced by Weiyan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Peng. The network helps show where Weiyan Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyan Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 132 | |
| 2 | 2013 | 97 | |
| 3 | 2020 | 88 | |
| 4 | 2018 | 85 | |
| 5 | 2013 | 82 | |
| 6 | 2015 | 76 | |
| 7 | 2013 | 62 | |
| 8 | 2016 | 48 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 43 | |
| 11 | 2019 | 38 | |
| 12 | 2021 | 37 | |
| 13 | OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling. | 2015 | 31 |
| 14 | 2018 | 29 | |
| 15 | 2014 | 26 | |
| 16 | 2017 | 25 | |
| 17 | 2016 | 25 | |
| 18 | 2021 | 23 | |
| 19 | 2022 | 22 | |
| 20 | 2018 | 21 |
About Weiyan Peng
Weiyan Peng is a scholar working on Molecular Biology, Physiology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (12 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Erythrocyte Function and Pathophysiology (6 papers), RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (3 papers), Blood properties and coagulation (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Cancer Research (246 citations), Molecular Biology (711 citations), Complementary and alternative medicine (64 citations), Oncology (171 citations) and Immunology (105 citations). Weiyan Peng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Tingxiu Xiang, Guosheng Ren, Zhu Qiu, Lili Li, Qian Tao, Xuedong Yin, Jun Tang, Junhao Mu, Jing Huang and Hongzhong Li. Their work appears in journals such as Theranostics, Journal of Cellular and Molecular Medicine, Clinical Epigenetics, Oncotarget and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.